KRAS G12D inhibitor 16
Modify Date: 2024-04-07 00:03:50
KRAS G12D inhibitor 16 structure
|
Common Name | KRAS G12D inhibitor 16 | ||
|---|---|---|---|---|
| CAS Number | 2648221-12-7 | Molecular Weight | 682.59 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C32H39IN6O3 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of KRAS G12D inhibitor 16KRAS G12D inhibitor 16 is a KRAS G12D inhibitor. KRAS G12D inhibitor 16 has inhibitory activity against KRAS G12D and KRAS G12D mutation with IC50 value of 0.7 nM and 0.35 μM, respectively. KRAS G12D inhibitor 16 can be used for the research of many malignant tumor, such as pancreatic ductal adenocarcinomas (PDAC), colon and rectal carcinomas (CRC), non-small cell lung carcinomas (NSCLC)[1]. |
| Name | KRAS G12D inhibitor 16 |
|---|
| Description | KRAS G12D inhibitor 16 is a KRAS G12D inhibitor. KRAS G12D inhibitor 16 has inhibitory activity against KRAS G12D and KRAS G12D mutation with IC50 value of 0.7 nM and 0.35 μM, respectively. KRAS G12D inhibitor 16 can be used for the research of many malignant tumor, such as pancreatic ductal adenocarcinomas (PDAC), colon and rectal carcinomas (CRC), non-small cell lung carcinomas (NSCLC)[1]. |
|---|---|
| Related Catalog | |
| Target |
KRas G12D:0.7 nM (IC50) |
| In Vitro | KRAS G12D inhibitor 16 has inhibitory activity for G12 with an IC50 value of 0.7 nM[1]. KRAS G12D inhibitor 16 shows growth inhibition activity KRAS-G12D mutant cell line (A-427) with an IC50 value of 0.35 μM[1]. |
| References |
| Molecular Formula | C32H39IN6O3 |
|---|---|
| Molecular Weight | 682.59 |